n(g),n(g')-dimethyl-l-arginine has been researched along with Arterial Occlusive Diseases in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 9.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 7.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 5.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 3.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| " Mechanisms responsible for endothelial dysfunction in hyperhomocyst(e)inemia may involve impaired bioavailability of NO, possibly secondary to accumulation of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) and increased oxidative stress." | 2.71 | ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Frölich, JC; Hornig, B; Schwedhelm, E; Sydow, K; Tsikas, D, 2003) |
| "Patients with type 2 diabetes (T2DM) have higher incidence of macrovascular disease than the general population." | 1.33 | Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. ( Hofer, M; Krugluger, W; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnack, C; Wolzt, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oz, O | 1 |
| Gökçil, Z | 1 |
| Bek, S | 1 |
| Cakir, E | 1 |
| Odabaşi, Z | 1 |
| Sydow, K | 2 |
| Schwedhelm, E | 1 |
| Arakawa, N | 2 |
| Bode-Böger, SM | 5 |
| Tsikas, D | 3 |
| Hornig, B | 2 |
| Frölich, JC | 3 |
| Böger, RH | 5 |
| Münzel, T | 1 |
| Krzyzanowska, K | 1 |
| Mittermayer, F | 1 |
| Krugluger, W | 1 |
| Schnack, C | 1 |
| Hofer, M | 1 |
| Wolzt, M | 1 |
| Schernthaner, G | 1 |
| Blardi, P | 1 |
| de Lalla, A | 1 |
| Pieragalli, D | 1 |
| De Franco, V | 1 |
| Meini, S | 1 |
| Ceccatelli, L | 1 |
| Auteri, A | 1 |
| Lücke, T | 1 |
| Kanzelmeyer, NK | 1 |
| Boerkoel, CF | 1 |
| Clewing, JM | 1 |
| Vaske, B | 1 |
| Ehrich, JH | 1 |
| Das, AM | 1 |
| Thiele, W | 2 |
| Junker, W | 1 |
| Alexander, K | 2 |
| Creutzig, A | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Topics: Arginine; Arterial Occlusive Diseases; Arteriosclerosis; Endothelium, Vascular; Humans; Nitric Oxide | 1997 |
3 trials available for n(g),n(g')-dimethyl-l-arginine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Topics: Aged; Analysis of Variance; Arginine; Arterial Occlusive Diseases; Double-Blind Method; Female; Foli | 2003 |
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Blood Platelets; Blood Pressure; Dia | 2006 |
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Ch | 1998 |
5 other studies available for n(g),n(g')-dimethyl-l-arginine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?
Topics: Adult; Anticonvulsants; Arginine; Arterial Occlusive Diseases; Carbamazepine; Drug Monitoring; Epile | 2009 |
Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Chronic Disease; Endothelium, | 2004 |
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Topics: Aged; Arginine; Arterial Occlusive Diseases; Biomarkers; Chromatography, High Pressure Liquid; Cross | 2006 |
Vaso-occlusion in Schimke-immuno-osseous dysplasia: is the NO pathway involved?
Topics: Adolescent; Adult; Arginine; Arterial Occlusive Diseases; Atherosclerosis; Child; Child, Preschool; | 2006 |
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Arterial Occlusive Diseases; Cyclic GMP; Disease Pr | 1997 |